Navigation Links
NanoMedicine Summit Returns to Cleveland, September 25-26
Date:7/8/2008

ar, the Summit's steering committee aims to build on the momentum of the 2004 and 2006 events, by connecting leaders at the forefront of nanotechnology who are developing cutting edge, next-generation nanotechnology products and solutions for the healthcare industry. Since nanoparticles are becoming increasingly used in innovative research for the development of medical applications and devices, this year's Summit will highlight the impact these unique nanostructures are having on diagnosis and treatment of disease.

"NanoMedicine is an emerging and expanding field with myriad applications and may play an important role is translational research - or moving laboratory research to patient care," said Vinod Labhasetwar, PhD, Director of Cleveland Clinic's Cancer NanoMedicine Program. "The applications of NanoMedicine are vast and may lead to the development of new diagnostic tools, early disease detection and new drug therapies." Cleveland Clinic's Cancer NanoMedicine Program is a joint program of the Lerner Research Institute's Department of Biomedical Engineering and Taussig Cancer Institute.

Topics to be covered at the summit include the use of nanoparticles for:

-- Imaging cancer and other diseases

-- Drug delivery

-- Treatment of disease

-- Biological investigation

-- Basic nanomedicine research

Confirmed speakers for the 2008 NanoMedicine Summit are top nanoscientists and business professionals from around the country, including leading biomedical researchers, clinician investigators, technologists from public and private companies, and medical industry thought leaders.

"Case Western Reserve University is pleased to welcome these renowned scientists to Cleveland. The recent award of a Biomedical Research and Commercialization Grant from the State of Ohio in nanomedical technology with Case Western Reserve University as lead institution testifies to the emphasis on this promising field on our campus,
'/>"/>

SOURCE The Nano-Network
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
2. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
3. MHA Announces: Tommy Thompson to be Keynote Speaker at The MHA 5th Annual Business Summit
4. Lux Executive Summit announces 2007 speakers
5. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
6. Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI
7. The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit
8. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
9. Summit VetPharm Addressed Veterinarian Diverted Vectra 3D(TM)
10. NeoStem to Present at Third Annual Stem Cell Summit in New York City
11. Alta Bates Summit Medical Center Opens Two Warm, Supportive Patient Centers: Carol Ann Read Breast Health Center and Family Resource Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015 Immunovaccine Inc. (“Immunovaccine”) (TSX: ... today announced that the U.S. Food and Drug ... designation and Phase I clinical trials of the ... mutual co-development agreement signed with Gilead Life Sciences. ... for the DPX-Survivac. , “We have been in ...
(Date:2/27/2015)... 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... with patients and health care advocates in the United ... Day®. Rare Disease Day is dedicated to elevating ... the special challenges faced by patients with rare diseases ... proud to stand alongside patients and caregivers representing the ...
(Date:2/26/2015)... 26, 2015  23andMe, the leading personal genetics company, ... as Privacy Officer and Corporate Counsel. Black brings a ... as well as health care regulations. As a member ... responsible for reviewing, updating and enhancing the company,s privacy ... abroad. She joined the company January 5, 2015 and ...
(Date:2/26/2015)... , Feb. 26, 2015 DuPont Executive ... priorities driven by key research advancements and product launches ... today,s Bank of America Merrill Lynch 2015 Global Agriculture ... challenge of building grain supplies the last two years, ... at the pace of the last decade, when demand ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... (Nasdaq: ONTY ), a biotechnology company specializing in ... of cancer, today announced that it intends to release ... 11, 2009 after market close. Following the release, Oncothyreon,s ... a general business update in a conference call at ...
... PUNE, India, November 2 TeleDiagnosys based ... services has signed up,several new clients from US and ... Teleradiology services to an international clientele in,countries like USA, ... Teleradiology involves transmitting MRI, CT Scan and ...
... Cardium Therapeutics (NYSE Amex: CXM ) today ... the U.S. Food and Drug Administration (FDA) seeking marketing ... Excellagen XL is an advanced wound care management ... designed for use by physicians in patients with topical ...
Cached Biology Technology:MRI & X-Ray Outsourcing Increasing From Hospitals and Imaging Centers Worldwide 2Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 2Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 3Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 4
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... IRVINE, Calif. , Jan. 27, 2015 ... trusted provider of globally deployed, innovative test ... today announced the delivery of its ... Martin Space Systems Company (LMSSC). GENASYS is ... the demands of mission-critical applications that require ...
(Date:2/5/2015)... 2015 Despite a lack of advancements ... as consumer electronics, automotive, storage and telecommunication has ... (SMT) screen printers. Innovations in electronics and conversion ... the adoption curve up. Meanwhile, sale volumes of ... dispensers are indispensable in the production of complex ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
... Consumption of foods high in carbohydrates immediately after birth ... University at Buffalo animal study has found, even if caloric ... The research on laboratory animals was published this month ... ; it was published online in December. "This is ...
... Braconidae are known for their deadly reproductive habits. Most ... in other insects and their larvae, eventually killing the respective ... sterility. Three new species of the parasitoid wasp genus ... Hymenoptera Research , reflect this fatal behavior. Two ...
... Trademark Office today awarded St. Jude Children,s Research Hospital ... compositions for genetically modifying human immune cells so they ... cancer in children and adults. "This ... attack certain cells that cause leukemia and lymphoma, cancers ...
Cached Biology News:High-carb intake in infancy has lifelong effects, UB study finds 2High-carb intake in infancy has lifelong effects, UB study finds 3Kill Bill character inspires the name of a new parasitoid wasp species 2St. Jude Children's Research Hospital announces issuance of US patent for cancer therapy 2